Marex Group plc

NasdaqGS:MRX Stock Report

Market Cap: US$3.6b

Marex Group Future Growth

Future criteria checks 2/6

Marex Group's revenue is forecast to decline at 7.3% per annum while its annual earnings are expected to grow at 14.9% per year. EPS is expected to grow by 8.2% per annum. Return on equity is forecast to be 21.2% in 3 years.

Key information

14.9%

Earnings growth rate

8.21%

EPS growth rate

Capital Markets earnings growth11.5%
Revenue growth rate-7.3%
Future return on equity21.22%
Analyst coverage

Good

Last updated06 May 2026

Recent future growth updates

Recent updates

Narrative Update • May 07

MRX: Higher Margins And Q1 2026 Outlook Will Support Measured Upside

Analysts have lifted Marex Group's price target from $50.29 to $55.00 as they now factor in a higher profit margin of about 20.9% and a lower future P/E of roughly 9.7, despite softer revenue growth assumptions and a slightly higher discount rate. What's in the News Marex Group issued earnings guidance for the first quarter ended March 31, 2026, with expected revenues in a range of $667 million to $697 million, compared with Q1 2025 revenues of $467 million (Key Developments).
Narrative Update • Apr 22

MRX: Higher Fair Value And Lower Future P/E Will Support Upside

Analysts have lifted their fair value estimate for Marex Group from $61.00 to $66.00, citing updated assumptions for modest positive revenue growth, a slightly higher profit margin, and a lower future P/E of 11.40 compared with the prior 13.35. What's in the News Marex Group issued earnings guidance for the quarter ending March 31, 2026, with expected revenues in a range of $667 million to $697 million, compared with Q1 2025 revenues of $467 million (Key Developments).
Narrative Update • Apr 07

MRX: Rich Earnings Multiple Will Face Test From Softer Revenue Outlook

Analysts have inched their price targets for Marex Group higher by a few dollars into the mid $40s, reflecting updated views on revenue trends, margins, and a lower forward P/E assumption in recent TD Cowen, Piper Sandler, and Barclays research. Analyst Commentary Recent research reflects a mixed tone, with some optimism on Marex Group's revenue and margin outlook, alongside more cautious views on where the shares should trade relative to sector peers.
Narrative Update • Mar 24

MRX: Volatility And Trading Volumes Will Test Fairly Priced Shares

Analysts have lifted their average price target on Marex Group by mid single digits. Recent moves include $7 and $5 increases, citing updated assumptions for revenue trends, profit margins, and a lower implied future P/E multiple despite a slightly higher discount rate.
Narrative Update • Mar 09

MRX: Higher Trading Volumes And Supportive P/E Will Drive Future Upside

Analysts have lifted their average price target on Marex Group to $61, citing updated views on revenue trajectory, profit margins, and a modestly higher future P/E multiple informed by recent Street research revisions from TD Cowen, Piper Sandler, and Barclays. Analyst Commentary Bullish analysts are leaning into Marex Group's execution by lifting their individual price targets, which helps explain the higher Street average.
Narrative Update • Feb 23

MRX: Rising Trading Volumes And Volatility Will Support Earnings Power

Narrative update on Marex Group Analysts have nudged their Marex Group price targets higher by $7 and $5 in recent updates, while one cut a target by $1 to $49. These changes reflect adjusted views on volumes, volatility, and earnings potential rather than a change to our $61 fair value estimate.
Narrative Update • Feb 07

MRX: Higher Volatility And Volumes Will Support Earnings Power Going Forward

The analyst price target for Marex Group has increased from $56 to $61, with analysts citing updated views on revenue trends, profit margins, and future P/E assumptions reflected in recent research from TD Cowen, Piper Sandler, and Barclays. Analyst Commentary Recent research updates show bullish analysts lifting their fair value estimates for Marex Group, with the latest round of work incorporating refreshed views on revenue trends, margin resilience, and P/E assumptions.
Narrative Update • Jan 23

MRX: US Expansion And Higher Trading Volumes Will Support Future Upside

Analysts have raised their price targets on Marex Group, reflecting a revised fair value estimate from $47.71 to $50.29 as they factor in updated expectations around volumes, revenue trends, margins, and future P/E assumptions following recent sector research. Analyst Commentary Recent research updates on Marex Group show a mix of optimism and caution as analysts refresh their models ahead of upcoming results and sector comparisons.
Narrative Update • Jan 08

MRX: Rising Trading Activity Will Support Earnings Power Despite Slight Price Trim

Analysts have trimmed their price target on Marex Group to US$49 from US$50, citing refreshed views on sector volumes and volatility while keeping fair value and key valuation inputs broadly unchanged. Analyst Commentary Bullish analysts are treating the lower US$49 price target as a fine tuning rather than a reset, keeping their broader view on Marex Group intact while they refresh assumptions for sector activity.
Narrative Update • Dec 23

MRX Will Benefit From Expanding US Structured Products And Margin Resilience

Analysts have trimmed their price target on Marex Group by 4 percent to $56.00, citing slightly higher discount rates and weaker revenue growth expectations, partly offset by improved profit margin forecasts and a more attractive forward earnings multiple. What's in the News Marex Group launched a US structured products business targeting RIAs, broker dealers, and private banks.
Narrative Update • Dec 09

MRX: US Expansion Will Drive Future Upside Despite Pending Securities Lawsuits

Narrative Update on Marex Group Price Target Analysts have modestly reduced their averaged price target on Marex Group from approximately $49.00 to about $47.70. This reflects slightly weaker top line growth assumptions, partially offset by expectations for improved profit margins and a marginally lower future price to earnings multiple.
Seeking Alpha • Dec 01

Unfortunate Post-IPO Realities Have Set In For Marex Group

Summary Marex Group (MRX) is rated Hold due to slowing earnings growth and recent reliance on non-organic growth. MRX has pursued aggressive acquisitions, improving diversification but raising risks of shareholder dilution and integration challenges. The company maintains strong revenue growth and a conservative dividend payout, but its yield remains below industry averages. Despite its current attractive valuation, future prospects for profit growth and mixed insider activity limit the stock's near-term upside potential. Read the full article on Seeking Alpha
Narrative Update • Nov 25

MRX: Diversified US Expansion Will Drive Recovery Despite Securities Lawsuit Risk

Analysts have raised their price target for Marex Group from $47.67 to $49.00, citing updated assumptions around profit margins and discount rates, which support a modestly higher valuation. What's in the News Marex Group has launched its structured products business in the United States, led by Scott Kerbel.
Narrative Update • Nov 06

MRX: Revenue Outlook Will Support Rebound Despite Ongoing Class Action Lawsuits

Analysts have made a minor upward adjustment to the price target for Marex Group, now set at $47.67. This change is based on slight improvements in the revenue growth outlook and a stable discount rate.
Narrative Update • Oct 23

Analysts Lower Marex Group Price Target Amid Accounting Allegations and Revised Profit Outlook

Analysts have slightly lowered their price target for Marex Group from $49.33 to $47.67. This change reflects recent updates to the company’s growth and profitability outlook.
Narrative Update • Oct 08

Digitalization And M&A Will Unlock Global Market Potential

Analysts have lowered their price target for Marex Group from $50.89 to $49.33, citing slightly reduced profit margin forecasts and modestly improved revenue growth projections. What's in the News NINGI Research disclosed a short position in Marex Group, alleging the company used opaque off-balance-sheet entities, fictitious transactions, and misleading disclosures to obscure losses and inflate profits (Periodical).
Analysis Article • Aug 06

Here's Why Marex Group (NASDAQ:MRX) Has Caught The Eye Of Investors

NasdaqGS:MRX 1 Year Share Price vs Fair Value Explore Marex Group's Fair Values from the Community and select yours...
User avatar
New Narrative • Apr 27

Acquisitions Will Fuel APAC And Middle East Expansion

Strong market share gains and acquisition integration are driving revenue growth and expanding product offerings and geographic reach.
Analysis Article • Apr 10

Further Upside For Marex Group plc (NASDAQ:MRX) Shares Could Introduce Price Risks After 26% Bounce

Marex Group plc ( NASDAQ:MRX ) shareholders have had their patience rewarded with a 26% share price jump in the last...
Analysis Article • Dec 25

Many Still Looking Away From Marex Group plc (NASDAQ:MRX)

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 19x, you may...

Earnings and Revenue Growth Forecasts

NasdaqGS:MRX - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20282,855511N/AN/A3
12/31/20272,588439N/AN/A7
12/31/20262,567397N/AN/A3
3/31/20263,266334N/AN/AN/A
12/31/20252,870294648668N/A
9/30/20252,668266N/AN/AN/A
6/30/20252,6082511,6171,639N/A
3/31/20252,530234N/AN/AN/A
12/31/20242,3572051,1441,164N/A
9/30/20242,142189N/AN/AN/A
6/30/20241,883134N/AN/AN/A
3/31/20241,849140N/AN/AN/A
12/31/20231,882128723735N/A
9/30/20231,092140N/AN/AN/A
6/30/20231,818139N/AN/AN/A
3/31/20231,570115N/AN/AN/A
1/1/20231,01092216226N/A
1/1/202282557464471N/A
12/31/202075844-51-46N/A
12/31/201954936N/A-23N/A
12/31/201838410N/A130N/A
12/31/201731818N/A-96N/A
12/31/201632820N/A30N/A
12/31/201534618N/A8N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: MRX's forecast earnings growth (14.9% per year) is above the savings rate (3.5%).

Earnings vs Market: MRX's earnings (14.9% per year) are forecast to grow slower than the US market (16.4% per year).

High Growth Earnings: MRX's earnings are forecast to grow, but not significantly.

Revenue vs Market: MRX's revenue is expected to decline over the next 3 years (-7.3% per year).

High Growth Revenue: MRX's revenue is forecast to decline over the next 3 years (-7.3% per year).

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: MRX's Return on Equity is forecast to be high in 3 years time (21.2%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/07 12:28
End of Day Share Price 2026/05/07 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Marex Group plc is covered by 13 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Benjamin BudishBarclays
Christopher AllenCitigroup Inc
Alexander BlosteinGoldman Sachs